Click here to go to the previous page
Use It Early and Often: Epidemiology's Many Roles in Clinical Development and Beyond
Program Code:
171
Date:
Monday, June 25, 2012
Time:
3:30 PM to 5:00 PM
EST
CHAIR
:
Nataliya Volkova, Pfizer Inc, United States
PRESENTER
(S):
After receiving her PhD and post-doctoral training, Dr. Brandenburg has worked within industry as a pharmacoepidemiologist for 18 years. Her current research activities in hemo-oncology are in both pre-approval and post-marketing settings.
|
Dr. Catherine Sigler is a Senior Epidemiologist with United BioSource Corporation. She has over 25 years of experience in pharmaceutical safety including epidemiologic study designs and risk management design and conduct. She is experienced with filing timelines and regulatory documentation.
|
Nataliya Volkova, Pfizer Inc, United States
Description
Seasoned epidemiologists use a framework of investigational, filing and post-marketing activities to bring to life the role of epidemiology in product support. Real world examples from actual projects are the basis for this session.
Learning Objectives:
Discuss the contributions of epidemiologists to in all phases of product development
Explain partnerships needed with development teams and unique challenges in communicating complex analyses
Evaluate case studies to illustrate the successful use of epidemiological data.